ABSTRACT
The volatile oil from traditional Chinese medicine has been widely used in medicine, food, agriculture and many other fields as its significant antibacterial effect on gram positive bacteria, gram negative bacteria, anaerobic bacteria and fungus.The clinical application is still not popular due to the poor stability.Cyclodextrin is used as the inclusion material to enhance the stability of volatile oil, make the preparation of production more convenient and the bioavailability improved.The literature referred to antibacterial volatile oil and the inclusion technology were summerized in order to provide reference to intensive study, optimize the technology of inclusion and develop more preparations.
ABSTRACT
This study is undertaken to modify the chitosan nanoparticles (CS-NPs) with wheat germ agglutinin (WGA), and investigate the conjugation between WGA-CS-NPs and N-acetylglucosamine (NAG). CS-NPs were prepared by ionotropic gelation process and then conjugated with WGA under the activation of glutaricdialdehyde. The mean diameter of the CS-NPs was approximately 113.5 nm and the poly-dispersity index (PDI) was 0.18. The binding yield of WGA to CS-NPs was comprised between 27.8% and 87.9% depending mostly on the addition of 0.3% (w/v) glutaraldehyde solution. A competitive inhibition experiment of WGA-CS-NPs to bovine submaxillary gland mucin (BSM) was taken to illuminate the binding activity of WGA-CS-NPs to the sugar of N-acetylglucosamine. After the addition of NAG, the binding rates between CS-NPs and BSM almost didn't change, while the binding rates between WGA-CS-NPs and BSM dropped down significantly, which confirmed the specific binding characteristics of WGA to NAG.
ABSTRACT
This study is to prepare scopolamine hydrobromide nanoparticles-in-microsphere system (SH-NiMS) and evaluate its drug release characteristics in vitro. SH nanoparticles were prepared by ionic crosslinking method with tripolyphosphate (TPP) as crosslinker and chitosan as carrier. Orthogonal design was used to optimize the formulation of SH nanoparticles, which took the property of encapsulation efficiency and drug loading as evaluation parameters. With HPMC as carrier, adjusted the parameters of spray drying technique and sprayed the SH nanoparticles in microspheres encaposulated by HPMC was formed and which is called nanoparticles-in-microsphere system (NiMS). SH-NiMS appearances were observed by SEM, structure was obsearved by FT-IR and the release characteristics in vitro were evaluated. The optimized formulation of SH nanoparticles was TPP/CS 1:3 (w/w), HPMC 0.3%, SH 0.2%. The solution peristaltic speed of the spray drying technique was adjusted to 15%, and the temperature of inlet was 110 degrees C. The encapsulation product yeild, drug loading and particle sizes of SH-NiMS were 94.2%, 20.4%, and 1256.5 nm, respectively. The appearances and the structure of SH-NiMS were good. The preparation method of SH-NiMS is stable and reliable to use, which provide a new way to develop new dosage form.
ABSTRACT
AIM To prepare lung targeted tetrandrine (TET) loaded sustained-release drug delivery system by microencapsulation, decrease the toxicity and enhance the therapeutic function of anti-pulmonary hypertension of TET. METHODS Albumin microcapsules were produced by spray drying-thermal denaturation, a new technique. Some characterization of the prepared microcapsules was evaluated. Distribution of the microcapsules and their anti-pulmonary hypertension effect in vivo were investigated. RESULTS The spherical microcapsules showed a drug loading of 37.88%. Compared to the original drug, the rate of TET released from the positively charged microcapsules in vitro was significantly decreased and fitted well by Higuchi equation. The TET concentrations in mouse lungs of TET microcapsules were significantly higher than those of TET injection, and the mean retained time of TET in lungs was prolonged from 157.1 h to 223.6 h after microencapsulation. The in vitro - in vivo correlation was established and confirmed (P＜0.001). CONCLUSION The new spray drying-thermal denaturation method allows the preparation of drug loaded albumin microcapsules with desired results. The prepared microcapsules were found to have the potential function of delivering TET to pulmonary artery via iv, with low toxicity and high efficacy.
ABSTRACT
AIM:To establish a HPLC method for determinaton of sodium ferulate (SF) in Beagle dog plasma and to study the pharmacokinetics of SF tablets. METHODS: Sodium ferulate in plasma was extracted with ether,separated on a Kromasil C_ 18 column (150 mm?4.6 mm,5 ?m) and the peak height ratio of sodium ferulate to the internal standard tinidazole was measured.Plasma concentration of SF was determined using acetonitrile-water-acetic acid(20∶79.2∶0.8) as the mobile phase and the flow rate was 0.8 ml/min.SF was detected at 320 nm. RESULTS: SF and the internal standard were separated completely under the condition described above.SF was linear in the range of 0.02～50 ?g/ml(r=0.9995).The accuracy,precision and sensitivity were eligible for analyse of bio-pharmic samples. CONCLUSION:A sensitive and accurate HPLC method for the quantitative determination of SF in the plasma of Beagle dog is developed and it is applicable to the determination in plasma and pharmacokinetic study of SF.